H-1152 Effects on Intraocular Pressure and Trabecular Meshwork Morphology of Rat Eyes
Overview
Pharmacology
Authors
Affiliations
Purpose: The aim of this study was to elucidate the effects of the Rho-kinase inhibitor, H-1152, on cultured human trabecular meshwork (HTM) cells, TM morphology, and intraocular pressure (IOP) in rats.
Methods: Cultured HTM cells were treated with H-1152. Changes in cell morphology and the organization of the actin cytoskeleton and focal adhesions were evaluated by microscopy and immunofluorescence. H-1152 was administered topically to the eyes of conscious rats, and IOP was measured with a commercially available tonometer before and after treatment. The eyes were enucleated 1 h after treatment, fixed, and processed for morphologic analysis by light and electron microscopy.
Results: Exposure of the cultured HTM cells to 20 microM of H-1152 induced elongation and separation of cells, deterioration, and loss of actin stress fibers and focal adhesions within 2 h. Topical administration of H-1152 resulted in a significant decrease in IOP from 0.5 to 6 h, with the maximum IOP reduction of 28.1% at 1 h post-treatment (P < 0.001; n = 10). H-1152 caused an expansion of the intercellular spaces and loss of extracellular material in the juxtacanalicular region of the TM in rat eyes.
Conclusions: The IOP-lowering effect of H-1152 in rat eyes is likely due to changes in TM-cell morphology, the actin cytoskeleton, and cellular adhesions in the conventional outflow pathway. H-1152 has potential as a new antiglaucoma medication.
Cell-Matrix Interactions in the Eye: From Cornea to Choroid.
Pouw A, Greiner M, Coussa R, Jiao C, Han I, Skeie J Cells. 2021; 10(3).
PMID: 33804633 PMC: 8003714. DOI: 10.3390/cells10030687.
Tan J, Wang X, Cai S, He F, Zhang D, Li D Mol Ther Methods Clin Dev. 2020; 17:143-155.
PMID: 31909087 PMC: 6938898. DOI: 10.1016/j.omtm.2019.11.017.
Tan J, Liu G, Zhu X, Wu Z, Wang N, Zhou L Mol Ther. 2019; 27(7):1327-1338.
PMID: 31129118 PMC: 6612778. DOI: 10.1016/j.ymthe.2019.04.021.
Rho kinase inhibitors for treatment of glaucoma.
Mandell K, Kudelka M, Wirostko B Expert Rev Ophthalmol. 2019; 6(6):611-622.
PMID: 30613208 PMC: 6319899. DOI: 10.1586/eop.11.65.
Effects of ripasudil, a rho kinase inhibitor, on blood flow in the optic nerve head of normal rats.
Wada Y, Higashide T, Nagata A, Sugiyama K Graefes Arch Clin Exp Ophthalmol. 2018; 257(2):303-311.
PMID: 30474717 DOI: 10.1007/s00417-018-4191-6.